サインイン

Rocco Sciarrillo

Department of Pediatric Oncology/Hematology,
Department of Hematology,
Department of Medical Oncology

VU University medical center

BIOGRAPHY

Rocco Sciarrillo has not added Biography.

If you are Rocco Sciarrillo and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.

European journal of medicinal chemistry Nov, 2011 | Pubmed ID: 21944286

Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.

Nature biotechnology Apr, 2014 | Pubmed ID: 24633243

Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cells.

Current drug targets , 2014 | Pubmed ID: 25483224

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor.

Oncotarget Dec, 2015 | Pubmed ID: 26015408

The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia.

Haematologica Jul, 2016 | Pubmed ID: 27036162

INSTITUTIONS

VU University medical center

JOVE ARTICLES

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Rocco Sciarrillo^1,2,3,

Anna Wojtuszkiewicz¹,

Irsan E. Kooi⁴,

Valentina E. Gómez³,

Ugo Boggi⁵,

Gerrit Jansen⁶,

Gert-Jan Kaspers^1,7,

Jacqueline Cloos^*,1,

Elisa Giovannetti^*,3,8,9

¹Department of Pediatric Oncology/Hematology, VU University Medical Center,

²Department of Hematology, VU University Medical Center,

³Department of Medical Oncology, VU University Medical Center,

⁴Department of Clinical Genetics, VU University Medical Center,

⁵Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa,

⁶Amsterdam Immunology and Rheumatology Center, VU University Medical Center,

⁷, Princess Máxima Center for Pediatric Oncology,

⁸Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa,

⁹Institute of Nanoscience and Nanotechnology, CNR-Nano

Cancer Research

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

Rocco Sciarrillo

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Pediatric Oncology/Hematology,Department of Hematology,Department of Medical Oncology

VU University medical center

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Department of Pediatric Oncology/Hematology,
Department of Hematology,
Department of Medical Oncology